Against this background, the observed association of the TNS1 rs918949 variant with the asthma–eczema comorbidity appears biologically plausible, suggesting that genetic variation within TNS1 may modulate barrier-related pathways, particularly relevant in multimorbid allergic disease. This evidence concerns the gene TNS1 and asthma.